WHITEHAWK THERAPEUTICS, INC. Shareholders' Equity
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Shareholders' Equity of $182.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $182.93M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $116.17M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $136.31M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $157.17M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $182.93M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $116.17M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $136.31M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $157.17M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $172.07M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $221.73M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $52.48M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $68.87M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $78.79M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $90.46M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $105.19M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $118.20M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $131.42M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $145.99M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $158.38M 10-K · filed 2025-03-28 | |
| 2022-09-30 | $169.11M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $108.73M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $124.63M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $136.41M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $150.93M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$19.37M 10-Q · filed 2022-11-09 | $35.22M 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$17.87M 10-Q · filed 2022-11-09 | $39.03M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$12.43M 10-K · filed 2023-03-29 | $43.06M 10-K · filed 2021-03-11 |
| 2020-09-30 | -$20.49M 10-Q · filed 2021-11-10 | $47.32M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$17.63M 10-Q · filed 2021-11-10 | $42.60M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$12.39M 10-Q · filed 2021-11-10 | $33.01M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$9.09M 10-K · filed 2022-03-17 | $36.54M 10-K · filed 2020-03-16 |
| 2019-09-30 | $41.71M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $45.72M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $50.80M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $58.67M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $66.52M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $47.91M 10-Q · filed 2019-11-07 | $47.91M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $11.11M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $17.44M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $23.42M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $27.94M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $33.31M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$86.22M 10-K · filed 2019-03-07 | -$225.91K 10-K · filed 2017-03-07 |
| 2016-09-30 | -$207.26K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$200.48K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$192.84K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$66.55M 10-K · filed 2018-03-15 | -$186.48K 10-K · filed 2016-03-30 |
| 2015-09-30 | -$174.65K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$168.13K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$160.86K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$155.04K 10-K · filed 2017-03-07 | |
| 2014-09-30 | -$143.39K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$136.96K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$130.01K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$124.24K 10-K · filed 2016-03-30 | |
| 2013-09-30 | -$114.49K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$108.35K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$101.60K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$95.54K 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$85.88K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$79.84K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$73.54K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$68.18K 10-K · filed 2015-02-27 | |
| 2011-09-30 | -$59.24K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$52.91K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$40.99K 10-K · filed 2015-02-27 | |
| 2009-12-31 | -$18.60K 10-K · filed 2015-02-27 | |
| 2008-12-31 | $1.40K 10-K · filed 2015-02-27 | |
| 2007-12-31 | $35.02K 10-K · filed 2015-02-27 | |
| 2007-11-16 | $0.00 10-K · filed 2012-03-30 | |
| 2007-11-14 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |